marijuana stocks

Players Network (PNTV)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue (132) 0   141   0  
Cost of Revenue (58) 77 191 46
Gross Profit (74) (77) (50) (46)
Operating Expenses
Research Development
Selling General and Administrative 196 1,311 246 537
Non Recurring
Others 7 7 7 6
Total Operating Expenses
Operating Income or Loss (278) (1,396) (302) (588)
Income from Continuing Operations
Total Other Income/Expenses Net (139) (245) 226 (320)
Earnings Before Interest And Taxes (416) (1,642) (77) (908)
Interest Expense 192 104 60 68
Income Before Tax (608) (1,746) (136) (976)
Income Tax Expense
Minority Interest 2 183
Net Income From Continuing Ops (249) (1,563) (136) (976)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (606) (1,563) (136) (976)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (606) (1,563) (136) (976)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Namaste Technologies Inc. (NXTTF) Announces Supply Agreement with Kief Cannabis

Namaste Announces Supply Agreement with Kief Cannabis Namaste Technologies Inc. (“Namaste” or…

$PLPL Biotechnology’s Production Facility Is an Intricate Maze

Plandai Biotechnology’s Production Facility Is an Intricate Maze of Proprietary Equipment Producing…

 Tetra Bio-Pharma Inc. (TBPMF) Provides Update on its Hepatocellular Carcinoma Drug HCC011

Tetra Bio-Pharma Provides Update on its Hepatocellular Carcinoma Drug HCC011  Tetra Bio-Pharma…

Lexaria Bioscience Corp. (LXRP) New Patent Application for Enhancement of Delivery of Lipophilic Agents

Lexaria Files New Patent Application for Enhancement of Delivery of Lipophilic Agents…